UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000003774
Receipt number R000004506
Scientific Title The effect of CES1A genetic polymorphism on the pharmacokinetics of Oseltamivir
Date of disclosure of the study information 2010/06/18
Last modified on 2013/02/19 00:45:15

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The effect of CES1A genetic polymorphism on the pharmacokinetics of Oseltamivir

Acronym

CES1A polymorphism and the pharmacokinetics of Oseltamivir

Scientific Title

The effect of CES1A genetic polymorphism on the pharmacokinetics of Oseltamivir

Scientific Title:Acronym

CES1A polymorphism and the pharmacokinetics of Oseltamivir

Region

Japan


Condition

Condition

Japanese healthy subjects

Classification by specialty

Not applicable

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

The aims of this study are to clarify the effect of CES1 genetic polymorphism on the pharmacokinetics of prodrug.

Basic objectives2

Pharmacokinetics

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase

Phase I


Assessment

Primary outcomes

AUC(Ro64-0802)

Key secondary outcomes

AUC (Oseltamivir), Cmax, C 12h, CL/f , Vd/f , tmax, t1/2, MRT (Oseltamivir and Ro64-0802), VAS


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

The subjects will be administered a single-dose 75 mg of Oseltamivir once.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) 20 years of age or older.
2) BMI between 18 and 30 kg/m2.
3) Subjects who are able to understand and follow instructions and who are able to participate in the study for the entire period.
4) Subjects must have given their written informed consent to participate in the study after receiving adequate previous information and prior to any study specific procedures.

Key exclusion criteria

1) The disease to need continuous medical treatment.
2) The liver and renal dysfunction and the psychic disease
3) Screening test results likely to show inappropriateness for participation in this study.
4) Febrile illness within 1 week before the first drug administration.
5) Subjects with a history of severe allergies, non-allergic drug reactions, or multiple drug allergies.
6) Use of any ethical drug medication within 1 week before the first drug administration.
7) Consumption of the grapefruit-containing beverages within 1 week before the first drug administration.
8) Consumption of the St. Jone's Wirt-containing supplement within 1 week before the first drug administration.
9) Consumption of the cigarettes within 1 week before the first drug administration.
10) Pregnancy or lactation in women.
11) Participation in a clinical trial of an investigational drug within 4 months or of an approved drug within 3 months before the first drug administration.
12) Blood donation of 400 mL of whole blood within 3 months or 200 mL of whole blood within 1 month or blood components (plasma and platelet) within 2 weeks before the first drug administration.
13) Any others judged by the investigators to be inappropriate for the subject of this study.

Target sample size

30


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yuki SUZAKI

Organization

Oita University Hospital

Division name

General Clinical Research Center

Zip code


Address

Hasama-machi, Yufu-shi, Oita

TEL

097-586-5954

Email



Public contact

Name of contact person

1st name
Middle name
Last name Yuki SUZAKI

Organization

Oita University Hospital

Division name

General Clinical Research Center

Zip code


Address

Hasama-machi, Yufu-shi, Oita

TEL

097-586-5954

Homepage URL


Email

ysuzaki@med.oita-u.ac.jp


Sponsor or person

Institute

Oita University Hospital

Institute

Department

Personal name



Funding Source

Organization

Japanese Research Foundation for Clinical Pharmacology

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

大分大学医学部附属病院(大分大学)


Other administrative information

Date of disclosure of the study information

2010 Year 06 Month 18 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2010 Year 05 Month 25 Day

Date of IRB


Anticipated trial start date

2010 Year 06 Month 01 Day

Last follow-up date

2010 Year 08 Month 01 Day

Date of closure to data entry

2010 Year 12 Month 01 Day

Date trial data considered complete

2010 Year 12 Month 01 Day

Date analysis concluded

2011 Year 08 Month 01 Day


Other

Other related information



Management information

Registered date

2010 Year 06 Month 17 Day

Last modified on

2013 Year 02 Month 19 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000004506


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name